Medical Progress Today
mpt home | sign up

Volume 3, Number 31
September 15, 2006


PRINTER FRIENDLY

News

Stanford Bans Taking Freebies From Drug Companies
Los Angeles Times, 9-13-06

Editor's Notes:

Pharmaceutical and medical device companies have been widely criticized for exerting an untoward influence on medical practice by "detailing" doctors and promoting newer and pricier products over the old reliables. Critics have called for the elimination of "commercialism" from the practice of medicine.
Continue reading . . .

Study Finds Higher Risk of Heart Attack with Vioxx
The New York Times, 9-13-06

Editor's Notes:

This article provides yet more grist for the litigation mill, recounting new studies in a recent issue of the Journal of the American Medical Association detailing the relative risks of Vioxx compared to other widely used painkillers:
Continue reading . . .

Government Sets Higher Medicare Rates and New Surcharge
The New York Times, 9-13-06

Editor's Notes:

CMS Administrator Mark McClellan has helped navigate Medicare through turbulent waters, including the adoption of the Medicare Part D drug benefit. But one of the least noticed changes to Medicare under his watch may turn out to be the greatest harbinger of things to come: means-testing for Medicare recipients.
Continue reading . . .

Commentary

Apples and Oranges
Grace-Marie Turner, Galen Institute, 9-15-06

Turner takes issue with a recent study from the Commonwealth Fund purporting to show that individuals who purchase their own health insurance are less satisfied than those who have employer-based policies.
Continue reading . . .

Medical Tourism: Why Americans Take Medical Vacations Abroad
Diana M. Ernst, Pacific Research Institute, 9-15-06

Ernst examines the phenomenon of Americans seeking medical treatment abroad and concludes that much of the impetus for medical tourism can be laid at the doorstep of high domestic prices—and bad health care policies.
Continue reading . . .

Medicare: The Monster at Our Door
Robert J. Samuelson, Real Clear Politics, 9-13-06

Washington Post columnist Robert Samuelson has made entitlement reform a regular—and powerful—topic of discussion in his writing. And he focuses like a laser beam on what should be the fundamental question underlying entitlement reform: "What's good for America?"
Continue reading . . .

I Cannot Support Socialized Medicine
Arnold Schwarzenegger, The San Diego Union-Tribune, 9-5-06

California Governor Arnold Schwarzenegger defends his decision to veto California Senate Bill 840, which would create a "single payer" health care system for all California residents by, among other things, outlawing private insurance.
Continue reading . . .

Counterfeit Drugs: Coming to a Pharmacy Near You
Wyatt Yankus, ACSH, 8-24-06

Yankus warns that counterfeit medicines pose a growing threat to consumer health, and that U.S. regulators and companies need to improve their efforts to protect the U.S. drug supply.
Continue reading . . .

Research

The Emerging Market Dynamics Of Targeted Therapeutics
John Calfee, Elizabeth DuPre, Health Affairs, 8-15-06

Calfee and DuPre look at the market for targeted therapeutic drugs and speculate on how the absence of a clear path for biogenerics may affect competition, pricing and research prospects for these powerful medicines.
Continue reading . . .


Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

In this week's issue:

NEWS

Stanford Bans Taking Freebies From Drug Companies
Study Finds Higher Risk of Heart Attack with Vioxx
Government Sets Higher Medicare Rates and New Surcharge

COMMENTARY

Apples and Oranges
Medical Tourism: Why Americans Take Medical Vacations Abroad
Medicare: The Monster at Our Door
I Cannot Support Socialized Medicine
Counterfeit Drugs: Coming to a Pharmacy Near You

RESEARCH

The Emerging Market Dynamics Of Targeted Therapeutics
Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org